During the past decade, Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen" are "Lennox Gastaut Syndrome" (1 trials), "Muscular Atrophy, Spinal" (1 trials) and "Spinal Muscular Atrophy" (1 trials). Many other conditions were trialed in "Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Risdiplam" (2 trials), "Matching Placebo" (1 trials), "Placebo" (1 trials) and "ZX008 0.2 or 0.8 mg/kg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".